Principal Securities, Inc. Atai Life Sciences N.V. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Principal Securities, Inc. holds 229 shares of ATAI stock, worth $1,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
229Holding current value
$1,167% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
111Shares Held
31.3MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$39.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$27.7 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$17.8 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$13.5 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$6.67 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $846M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...